Ray Dalio Qiagen N.V. Transaction History

Bridgewater Associates, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$39.13 - $47.24 $1.93 Million - $2.33 Million	-49,354 Reduced 38.03%	80,429 $3.26 Million
Q2 2023 Aug 11, 2023	SELL	$43.93 - $46.76 $2.18 Million - $2.32 Million	-49,691 Reduced 27.69%	129,783 $5.84 Million
Q1 2023 May 12, 2023	BUY	$45.29 - $50.76 $1.07 Million - $1.2 Million	23,687 Added 15.2%	179,474 $8.24 Million
Q4 2022 Feb 13, 2023	BUY	$41.91 - $50.48 $71,037 - $85,563	1,695 Added 1.1%	155,787 $7.77 Million
Q3 2022 Nov 10, 2022	BUY	$40.9 - $50.42 $4.42 Million - $5.45 Million	108,049 Added 234.67%	154,092 $6.36 Million
Q2 2022 Aug 11, 2022	BUY	$42.98 - $49.77 $19,383 - $22,446	451 Added 0.99%	46,043 $2.17 Million
Q1 2022 May 13, 2022	BUY	$42.23 - $54.3 $169,511 - $217,960	4,014 Added 9.65%	45,592 $2.23 Million
Q4 2021 Feb 14, 2022	SELL	$50.62 - $56.47 $2,733 - $3,049	-54 Reduced 0.13%	41,578 $2.31 Million
Q3 2021 Nov 12, 2021	BUY	$46.55 - $56.83 $468,572 - $572,050	10,066 Added 31.89%	41,632 $2.15 Million
Q2 2021 Aug 13, 2021	BUY	$46.28 - $52.75 $1.46 Million - $1.67 Million	31,566 New	31,566 $1.53 Million

6.37M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $10.5B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.